SLC16A1 and type 2 diabetes mellitus: Constructing Slc16a1 knockout mouse model demonstrated that SLC16A1 may contribute to the treatment of exercise-induced hyperinsulinemia (Pullen et al., 2012), at the same time, it may exacerbate ketoacidosis (Balasubramaniam et al., 2016).